These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22888148)

  • 1. Protein-protein-interaction network organization of the hypusine modification system.
    Sievert H; Venz S; Platas-Barradas O; Dhople VM; Schaletzky M; Nagel CH; Braig M; Preukschas M; Pällmann N; Bokemeyer C; Brümmendorf TH; Pörtner R; Walther R; Duncan KE; Hauber J; Balabanov S
    Mol Cell Proteomics; 2012 Nov; 11(11):1289-305. PubMed ID: 22888148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
    Pällmann N; Braig M; Sievert H; Preukschas M; Hermans-Borgmeyer I; Schweizer M; Nagel CH; Neumann M; Wild P; Haralambieva E; Hagel C; Bokemeyer C; Hauber J; Balabanov S
    J Biol Chem; 2015 Jul; 290(30):18343-60. PubMed ID: 26037925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
    Preukschas M; Hagel C; Schulte A; Weber K; Lamszus K; Sievert H; Pällmann N; Bokemeyer C; Hauber J; Braig M; Balabanov S
    PLoS One; 2012; 7(8):e43468. PubMed ID: 22927971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation.
    Sievert H; Pällmann N; Miller KK; Hermans-Borgmeyer I; Venz S; Sendoel A; Preukschas M; Schweizer M; Boettcher S; Janiesch PC; Streichert T; Walther R; Hengartner MO; Manz MG; Brümmendorf TH; Bokemeyer C; Braig M; Hauber J; Duncan KE; Balabanov S
    Dis Model Mech; 2014 Aug; 7(8):963-76. PubMed ID: 24832488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypusine: its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation.
    Park MH; Wolff EC; Folk JE
    Biofactors; 1993 May; 4(2):95-104. PubMed ID: 8347280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational synthesis of hypusine: evolutionary progression and specificity of the hypusine modification.
    Wolff EC; Kang KR; Kim YS; Park MH
    Amino Acids; 2007 Aug; 33(2):341-50. PubMed ID: 17476569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of active recombinant eIF5A: reconstitution in E.coli of eukaryotic hypusine modification of eIF5A by its coexpression with modifying enzymes.
    Park JH; Dias CA; Lee SB; Valentini SR; Sokabe M; Fraser CS; Park MH
    Protein Eng Des Sel; 2011 Mar; 24(3):301-9. PubMed ID: 21131325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A).
    Park MH
    J Biochem; 2006 Feb; 139(2):161-9. PubMed ID: 16452303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tandem affinity purification revealed the hypusine-dependent binding of eukaryotic initiation factor 5A to the translating 80S ribosomal complex.
    Jao DL; Chen KY
    J Cell Biochem; 2006 Feb; 97(3):583-98. PubMed ID: 16215987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked elevation of hypusine formation activity on eukaryotic initiation factor 5A in v-HA-RAS transformed mouse NIH3T3 cells.
    Chen ZP; Chen KY
    Cancer Lett; 1997 May; 115(2):235-41. PubMed ID: 9149130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique modification of the eukaryotic initiation factor 5A shows the presence of the complete hypusine pathway in Leishmania donovani.
    Chawla B; Kumar RR; Tyagi N; Subramanian G; Srinivasan N; Park MH; Madhubala R
    PLoS One; 2012; 7(3):e33138. PubMed ID: 22438895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational formation of hypusine in eIF5A: implications in human neurodevelopment.
    Park MH; Kar RK; Banka S; Ziegler A; Chung WK
    Amino Acids; 2022 Apr; 54(4):485-499. PubMed ID: 34273022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypusine is required for a sequence-specific interaction of eukaryotic initiation factor 5A with postsystematic evolution of ligands by exponential enrichment RNA.
    Xu A; Chen KY
    J Biol Chem; 2001 Jan; 276(4):2555-61. PubMed ID: 11060315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural features of the eIF-5A precursor required for posttranslational synthesis of deoxyhypusine.
    Joe YA; Park MH
    J Biol Chem; 1994 Oct; 269(41):25916-21. PubMed ID: 7929297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 Rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification.
    Liu YP; Nemeroff M; Yan YP; Chen KY
    Biol Signals; 1997; 6(3):166-74. PubMed ID: 9285100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the polyamine-hypusine circuit for the prevention and treatment of cancer.
    Nakanishi S; Cleveland JL
    Amino Acids; 2016 Oct; 48(10):2353-62. PubMed ID: 27357307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapy.
    Caraglia M; Tagliaferri P; Budillon A; Abbruzzese A
    Adv Exp Med Biol; 1999; 472():187-98. PubMed ID: 10736626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway.
    Schwentke A; Krepstakies M; Mueller AK; Hammerschmidt-Kamper C; Motaal BA; Bernhard T; Hauber J; Kaiser A
    BMC Microbiol; 2012 Jun; 12():107. PubMed ID: 22694849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.
    Schultz CR; Geerts D; Mooney M; El-Khawaja R; Koster J; Bachmann AS
    Biochem J; 2018 Jan; 475(2):531-545. PubMed ID: 29295892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation initiation factor 5A and its hypusine modification are essential for cell viability in the yeast Saccharomyces cerevisiae.
    Schnier J; Schwelberger HG; Smit-McBride Z; Kang HA; Hershey JW
    Mol Cell Biol; 1991 Jun; 11(6):3105-14. PubMed ID: 1903841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.